DeepUll

About

DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition.

Barcelona,Catalonia,Spain
1 - 10

Highlights

Details

Last Funding Type: Debt Financing
Last Funding Money Raised: €20M
Industries: Biotechnology,Life Science
Founded date: Jan 1, 2019
Number Of Employee: 1 - 10
Operating Status: Active

DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition.
DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functional status on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

3

€36.50M

DeepUll has raised a total of €36.50M in funding over 2 rounds. Their latest funding was raised on Dec 13, 2022 from a Debt Financing round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Dec 13, 2022	Debt Financing	€20M	1	European Investment Bank	—	Detail
Oct 20, 2022	Series B	€13M	5	Centre for the Development of Industrial Technology (CDTI)	—	Detail
Jul 7, 2020	Series A	€3.50M	2	Alta Life Sciences Kurma Partners	—	Detail

Investors

Number of Lead Investors

Number of Investors

4

6

DeepUll is funded by 6 investors. European Investment Bank and Centre for the Development of Industrial Technology (CDTI) are the most recent investors.

Investor Name	Lead Investor	Funding Round
European Investment Bank	Yes	Debt Financing
Centre for the Development of Industrial Technology (CDTI)	Yes	Series B
Alta Life Sciences	—	Series B
AXIS Participaciones Empresariales	—	Series B
Kurma Partners	—	Series B
UI Investissement	—	Series B